Ciprofloxacino cinfa

Medicinal product

(Invented) name

Ciprofloxacino cinfa

Active substance (s)

Ciprofloksacinas

Strength

250 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01MA02, Ciprofloxacin

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2026-09-16

Date of renewal

Documents

3599_Ciprofloxacino cinfa 250mg_pl_deng_tab_PZ 2026-09-16.docx

3599_Ciprofloxacino cinfa 250mg_pl_deng_tab_PL 2026-09-16.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ciprofloksacinas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122262	108374	1108374	lizdinė plokštelė	N14		Receptinis	LT/L/26/3599/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-09-16	Registruotas